Trials / Unknown
UnknownNCT02368613
A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate adequate-dose of DW-3102 in the treatment of hypercholesterolemia patients by conducting phase 2a. 4 groups involving placebo group, each groups are composed by 16, will be participated in this trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW-3102 |
Timeline
- Primary completion
- 2017-10-01
- First posted
- 2015-02-23
- Last updated
- 2016-10-10
Source: ClinicalTrials.gov record NCT02368613. Inclusion in this directory is not an endorsement.